Biohaven Ltd
BHVN
Market Cap$4.36B
Close$
$3.07
93% downside
Current Fair Value
93% downsideOvervalued by 93% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.36 Billion |
|---|---|
| Enterprise Value | $4.82 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 1.51 |
| Outstanding Shares | 81,596,082 |
| Avg 30 Day Volume | 1,306,941 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | 4.4 |
| Price to Book Ratio | -4.4 |
| Enterprise Value to Revenue | 5.61 |
| Enterprise Value to EBIT | -7.47 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | -1.26 |
Revenue Sources
No data
ESG Score
No data
About Biohaven Pharmaceutical Holding Company Ltd
CEO: Vlad Coric